The deal could be a big win for open source. Or it might not be.
The deal was put together by ValueAct Capital, a U.S. hedge fund which holds a big Misys stake. It will increase its stake through the deal, and Misys shares rose about 25% on the news, spurred by a special cash dividend.
Misys is the acquiring company in part because it's based in London, and at $2/pound that money is more fun to work with right now.
Allscripts posted a video interview with its CEO, Glen Tullman, and Misys' Mike Lawrie on its Web site. Tullman will run the combined company, which he said will have one-third of the physician EMR market.
Lawrie, however, said customers will have a choice between the two companies' offerings:
We are going to continue to support the products that we have out there...
But now Misys customers have a choice. Do they want to continue with that? Do they want to continue to look at some of those offerings, or do they want to take a look at some of the best of breed products that Allscripts has?
That, plus the companies' commitment to focus on Software as a Service (SaaS), may limit the number of future Misys code releases, so open source advocates need to watch carefully.